Study on the acquisition of Bleomycin (BLM) resistance in human epidermoid carcinoma cells. V Cross-resistance of three BLM-resistant cells to other antitumor agents. | Zendy

AI Assistant Blog Pricing

Study on the acquisition of Bleomycin (BLM) resistance in human epidermoid carcinoma cells. V Cross-resistance of three BLM-resistant cells to other antitumor agents.

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.